Literature DB >> 1986686

Prevalence of Mycobacterium avium complex in respiratory specimens from AIDS and non-AIDS patients in a San Francisco hospital.

P S Nassos1, D M Yajko, C A Sanders, W K Hadley.   

Abstract

Over the past several years there has been a large increase in the recovery of Mycobacterium avium complex (MAC) isolates from respiratory specimens submitted to the clinical laboratory at San Francisco General Hospital (SFGH). This increase in MAC recovery correlates with an increase in the number of cases of acquired immunodeficiency syndrome (AIDS) in the community. Although it is well known that MAC is often isolated from patients with AIDS, the isolation of MAC from respiratory specimens is often attributed to contamination of the specimen with MAC organisms present in the environment. To determine whether the increase in MAC isolates recovered at SFGH was due to an increase in environmental contamination of specimens or to the increase in our AIDS patient population, we conducted a study of the prevalence of MAC in respiratory specimens from AIDS versus non-AIDS patients. Results of specimens submitted to the clinical laboratory at SFGH for culture of mycobacteria were reviewed over a 12-yr period, from 1977 through 1988. The prevalence of MAC in respiratory specimens from AIDS and non-AIDS patients was determined for 4 yr during this period: the pre-AIDS year 1977; the first year AIDS was reported in San Francisco, 1981; 1984; and 1987. In 1977 and 1981 the prevalence of MAC in respiratory specimens was less than or equal to 0.5%, and all MAC isolates were recovered from non-AIDS patients. In 1984 the prevalence of MAC in respiratory specimens for AIDS and non-AIDS patients was 6.5 and 0.3%, respectively, and in 1987, 8.8 and 0.3%, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1986686     DOI: 10.1164/ajrccm/143.1.66

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

Review 1.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 2.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Impact of the human immunodeficiency virus epidemic on detection of Mycobacterium isolates in a general hospital.

Authors:  E Bouza; J Albadalejo; E Cercenado; M J Ruiz Serrano; T Vicente; A Ortega
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

4.  Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses.

Authors:  I M Orme; S K Furney; A D Roberts
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 5.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis.

Authors:  Lorenz Leitritz; Matthias Griese; Andreas Roggenkamp; Anna Maria Geiger; Volker Fingerle; Jürgen Heesemann
Journal:  Med Microbiol Immunol       Date:  2003-09-03       Impact factor: 3.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.